PF-06936308

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePF-06936308

Drug Alias NameVaccine-based immunotherapy regimen-2VBIR-2PF-06936308

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A